We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.68B
1-Year Est. Return 53.07%
This Fund
S&P 500
This Quarter Est. Return
-5.38%
1 Year Est. Return
+53.07%
3 Year Est. Return
+57.39%
5 Year Est. Return
+19.29%
10 Year Est. Return
+11.57%
AUM
$154M
AUM Growth
+$45.6M
Cap. Flow
+$52.3M
Cap. Flow %
34.03%
Top 10 Hldgs %
48.17%
Holding
68
New
31
Increased
8
Reduced
11
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 30.88%
2 Industrials 19.19%
3 Consumer Discretionary 15.28%
4 Communication Services 10.09%
5 Healthcare 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRSP
1
DELISTED
Perspecta Inc. Common Stock
PRSP
$12.5M 8.16%
+610,482
New +$13.7M
MDR
2
DELISTED
McDermott International
MDR
$10M 6.53%
510,917
-45,951
-8% -$933K
XRX icon
3
Xerox
XRX
$436M
$8.77M 5.7%
365,545
+321,046
+721% +$9.08M
AVYA
4
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$8.21M 5.34%
409,024
+241,261
+144% +$5.33M
DXC icon
5
DXC Technology
DXC
$1.86B
$8.19M 5.33%
+101,626
New +$8.73M
VIAB
6
DELISTED
Viacom Inc. Class B
VIAB
$5.63M 3.66%
+186,716
New +$5.49M
MGM icon
7
MGM Resorts International
MGM
$10.4B
$5.43M 3.53%
+187,076
New +$6.04M
FLXN
8
DELISTED
Flexion Therapeutics, Inc.
FLXN
$5.41M 3.52%
+209,340
New +$5.43M
SYNH
9
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$4.96M 3.22%
105,700
-243,979
-70% -$10.1M
BRSL
10
Brightstar Lottery PLC
BRSL
$2.06B
$4.89M 3.18%
+210,486
New +$5.6M
FLEX icon
11
Flex
FLEX
$40.5B
$4.74M 3.08%
+445,551
New +$5M
FG
12
DELISTED
FGL Holdings Ordinary Shares
FG
$4.32M 2.81%
515,034
-106,315
-17% -$969K
SPB icon
13
Spectrum Brands
SPB
$2.04B
$4.32M 2.81%
52,920
-16,056
-23% -$1.35M
AGN
14
DELISTED
Allergan plc
AGN
$4.22M 2.75%
25,335
+21,899
+637% +$3.52M
OSIS icon
15
OSI Systems
OSIS
$3.25B
$3.95M 2.57%
51,099
-83,849
-62% -$5.85M
CZR
16
DELISTED
Caesars Entertainment Corporation
CZR
$3.58M 2.32%
334,148
-142,899
-30% -$1.67M
RYAM icon
17
Rayonier Advanced Materials
RYAM
$575M
$3.25M 2.12%
+190,422
New +$3.67M
MSTR icon
18
Strategy Inc
MSTR
$56.7B
$3.19M 2.07%
249,520
+159,180
+176% +$2.07M
NSM
19
DELISTED
Nationstar Mortgage Holdings
NSM
$3.17M 2.06%
180,684
+120,610
+201% +$2.17M
GLIBA
20
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$3.09M 2.01%
+68,477
New +$3.16M
LKQ icon
21
LKQ Corp
LKQ
$6.46B
$3.03M 1.97%
+95,082
New +$3.17M
CMCSA icon
22
Comcast
CMCSA
$94B
$2.81M 1.83%
85,803
+35,783
+72% +$1.17M
MIK
23
DELISTED
Michaels Stores, Inc
MIK
$2.73M 1.78%
+142,428
New +$2.71M
WSCWW
24
DELISTED
WillScot Corporation Warrant
WSCWW
$2.59M 1.68%
1,144,071
+92,735
+9% +$141K
HWM icon
25
Howmet Aerospace
HWM
$103B
$2.57M 1.67%
+197,193
New +$2.93M

Similar funds

Clearline Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Clearline Capital held 68 positions worth $154M, up 42% from $108M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Clearline Capital deployed $52.3M of net new capital in Q2 2018, opening 31 new positions and adding to 8 existing holdings. Its largest new stake was Perspecta Inc. Common Stock: 610,482 shares worth $12.5M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Syneos Health, Inc. Class A Common Stock, an estimated $10.1M trimmed.

  • Clearline Capital's largest Q2 2018 buy was Perspecta Inc. Common Stock: 610,482 shares worth $12.5M.
  • Clearline Capital added most to Xerox in Q2 2018, an estimated $9.08M increase.
  • Clearline Capital's biggest Q2 2018 reduction was Syneos Health, Inc. Class A Common Stock, cutting an estimated $10.1M.
  • Clearline Capital fully exited Trinity Industries in Q2 2018, selling an estimated $7.89M.
  • Clearline Capital's ten largest holdings make up 48% of its $154M portfolio in Q2 2018.
  • Clearline Capital opened 31 new positions and closed 17 in Q2 2018.
  • Clearline Capital's portfolio value rose 42% quarter-over-quarter to $154M.

Based on Clearline Capital's 13F filing for Q2 2018, filed 14 Aug 2018.